A Frailty Scale Predicts Outcomes of Patients with Newly Diagnosed Multiple Myeloma Who Are Ineligible for Transplant Treated with Continuous Lenalidomide Plus Low-Dose Dexamethasone on the First Trial

被引：12

作者：

Facon, Thierry ^{[1
]}

Hulin, Cyrille ^{[2
]}

Dimopoulos, Meletios A. ^{[3
]}

Belch, Andrew ^{[4
]}

Meuleman, Nathalie ^{[5
]}

Mohty, Mohamad ^{[6
]}

Chen, Wen-Ming ^{[7
]}

Kim, Kihyun ^{[8
]}

Zamagni, Elena ^{[9
]}

Rodriguez-Otero, Paula ^{[10
]}

Renwick, William ^{[11
]}

Rose, Christian ^{[12
]}

Tempescul, Adrian ^{[13
]}

Palumbo, Antonio ^{[14
]}

Guo, Shien ^{[15
]}

Sturniolo, Michael ^{[16
]}

Ervin-Haynes, Annette ^{[16
]}

Fermand, Jean-Paul ^{[17
]}

机构：

[1] CHRU Lille, Hop Claude Huriez, Malad Sang, F-59037 Lille, France

[2] CHU BORDEAUX, Bordeaux, France

[3] Univ Athens, Sch Med, Athens 11528, Greece

[4] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada

[5] Univ Libre Bruxelles, Jules Bordet Insitute, Dept Hematol, Brussels, Belgium

[6] St Antoine Hosp, Dept Haematol, Paris, France

[7] Beijing Chaoyang Hosp, Beijing, Peoples R China

[8] Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea

[9] Azienda Osped Univ, Bologna, Italy

[10] Univ Navarra Clin, Pamplona, Spain

[11] Western Hlth, St Albans, Australia

[12] Hop St Vincent, Dept Hematol, Lille, France

[13] CHU Brest, Dept Hematol, F-29285 Brest, France

[14] Univ Turin, Turin, Italy

[15] Evidera, Boston, MA USA

[16] Celgene Corp, Summit, NJ USA

[17] Hop St Louis, AP HP, Serv Immunohematol, Paris, France

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

10.1182/blood.V126.23.4239.4239

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4